The Scientific and Clinical Advisors team at DayTwo plays a critical role in guiding the development and implementation of evidence-based interventions for metabolic diseases. Comprising experts in clinical practice and microbiome research, the team collaborates on clinical program design, evaluates research findings, and ensures the integration of cutting-edge scientific insights into patient care strategies. They strive to enhance the efficacy of DayTwo’s personalized approaches through rigorous scientific validation and clinical expertise.
Alan Spiro
Clinical Advisor
Dariush Mozaffarian
Scientific Advisor
Eran Elinav
Scientific Advisor
Eran Segal
Scientific Advisor
Jack A. Gilbert
Scientific Advisor
Jan Berger
Clinical Advisor
Mandy Seay Rdn
Director Of Clinical Programs
Rob Knight
Scientific Advisor
Ronald M. Krauss
Scientific Advisor
Yossi Cohen
Head Of Microbiome Research
View all